Cremolini, C., Ciracì, P., Pietrantonio, F., Lonardi, S., Germani, M. M., Busico, A., Manca, P., Ricagno, G., Pella, N., Formica, V., Scartozzi, M., Burgio, V., Donato, S. D., Moretto, R., Capone, I., Palermo, F., Marmorino, F., Masi, G., Boni, L., Rossini, D. (2025). Panitumumab retreatment followed by regorafenib versus the reverse sequence in chemorefractory metastatic colorectal cancer patients with
            <i>RAS</i>
            and
            <i>BRAF</i>
            wild-type circulating tumor DNA (ctDNA): Results of the phase II randomized PARERE trial by GONO.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.17_suppl.lba3515